CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 17 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38,441 | – | 44,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $7,899,833 | 0.15% |
| Kynam Capital Management, LP | 535,005 | $602,640 | 0.08% |
| Ikarian Capital, LLC | 219,501 | $243,645 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 603,900 | $670,329 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 650,000 | $734,500 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $30,360 | 0.00% |
| MORGAN STANLEY | 1 | $1 | 0.00% |
| Renaissance Technologies | 95,500 | $108 | 0.00% |
| ROYAL BANK OF CANADA | 35 | $0 | 0.00% |
| FMR LLC | 24 | $26 | 0.00% |